Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 925096, 8 pages
http://dx.doi.org/10.1155/2015/925096
Research Article

Evaluation of Antifungal Activity and Mode of Action of New Coumarin Derivative, 7-Hydroxy-6-nitro-2H-1-benzopyran-2-one, against Aspergillus spp.

1Pharmaceutical Science Department, Federal University of Paraíba, 58051-970 João Pessoa, PB, Brazil
2Laboratory of Synthesis and Drug Delivery, Biological Science Department, State University of Paraíba, 58020-540 João Pessoa, PB, Brazil
3Center of Education and Heath, Federal University of Campina Grande, 58175-000 Cuité, PB, Brazil

Received 2 April 2015; Revised 26 May 2015; Accepted 28 May 2015

Academic Editor: Filippo Maggi

Copyright © 2015 Felipe Queiroga Sarmento Guerra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Richardson, “Changing patterns and trends in systemic fungal infections,” Journal of Antimicrobial Chemotherapy, vol. 56, no. 1, pp. 5–11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Espinel-Ingroff, “Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005–2009),” Revista Iberoamericana de Micología, vol. 26, no. 1, pp. 15–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. T. J. Walsh, E. J. Anaissie, D. W. Denning et al., “Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of America,” Clinical Infectious Diseases, vol. 46, no. 3, pp. 327–360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. Amorim, L. Maria-Moreira, C. D. R. Amorim et al., “Infecções por Aspergillus spp: aspectos gerais,” Pulmão RJ, vol. 13, pp. 111–118, 2004. View at Google Scholar
  5. M. H. Miceli and S. A. Lee, “Emerging moulds: epidemiological trends and antifungal resistance,” Mycoses, vol. 54, no. 6, pp. e666–e678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Maggi, L. Barboni, G. Caprioli et al., “HPLC quantification of coumarin in bastard balm (Melittis melissophyllum L., Lamiaceae),” Fitoterapia, vol. 82, no. 8, pp. 1215–1221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Hamdi, A. S. Al-Ayed, R. B. Said, and A. Fabienne, “Synthesis and characterization of new thiazolidinones containing coumarin moieties and their antibacterial and antioxidant activities,” Molecules, vol. 17, no. 8, pp. 9321–9334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Johann, B. G. Mendes, F. C. Missau, M. A. de Resende, and M. G. Pizzolatti, “Antifungal activity of five species of Polygala,” Brazilian Journal of Microbiology, vol. 42, no. 3, pp. 1065–1075, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. S. A. de Araujo, F. Q. S. Guerra, E. D. O. Lima et al., “Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity,” International Journal of Molecular Sciences, vol. 14, no. 1, pp. 1293–1309, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. S. A. Khan and I. Ahmad, “Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum,” Applied Microbiology and Biotechnology, vol. 90, no. 3, pp. 1083–1094, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Cleeland and E. Squires, “Evalution of new antimicrobials in vitro and in experimental animal infections,” in Antibiotics in Laboratory Medicine, V. Lorian, Ed., pp. 739–786, Lippincott Williams & Wilkins, Baltimore, Md, USA, 3rd edition, 1991. View at Google Scholar
  12. F. Hadacek and H. Greger, “Testing of antifungal natural products: methodologies, comparability of results and assay choice,” Phytochemical Analysis, vol. 11, no. 3, pp. 137–147, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Sahin, M. Güllüce, D. Daferera et al., “Biological activities of the essential oils and methanol extract of Origanum vulgare ssp. vulgare in the Eastern Anatolia region of Turkey,” Food Control, vol. 15, no. 7, pp. 549–557, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Hadacek and H. Greger, “Testing of antifungal natural products: methodologies, comparability of results and assay choice,” Phytochemical Analysis, vol. 11, no. 3, pp. 137–147, 2000. View at Google Scholar · View at Scopus
  15. R. Cleeland and E. Squires, “Evaluation of new antimicrobials in vitro and in experimental animal infection,” in Antibiotics in Laboratory Medicine, Williams & Wilkins, New York, NY, USA, 1991. View at Google Scholar
  16. N. Sharma and A. Tripathi, “Effects of Citrus sinensis (L.) Osbeck epicarp essential oil on growth and morphogenesis of Aspergillus niger (L.) Van Tieghem,” Microbiology Research, vol. 163, no. 3, pp. 337–344, 2006. View at Publisher · View at Google Scholar
  17. F. de Oliveira Pereira, J. M. Mendes, and E. de Oliveira Lima, “Investigation on mechanism of antifungal activity of eugenol against Trichophyton rubrum,” Medical Mycology, vol. 51, no. 5, pp. 507–513, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. B. K. Rana, U. P. Singh, and V. Taneja, “Antifungal activity and kinetics of inhibition by essential oil isolated from leaves of Aegle marmelos,” Journal of Ethnopharmacology, vol. 57, no. 1, pp. 29–34, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Liu, Q. Zhang, L. Wang et al., “The use of global transcriptional analysis to reveal the biological and cellular events involved in distinct development phases of Trichophyton rubrum conidial germination,” BMC Genomics, vol. 8, article 100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. J. Frost, K. D. Brandt, D. Cugier, and R. Goldman, “A whole-cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly,” Journal of Antibiotics, vol. 48, no. 4, pp. 306–310, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. M. C. A. Leite, A. P. B. Bezerra, J. P. Sousa, F. Q. Guerra, and E. d. Lima, “Evaluation of antifungal activity and mechanism of action of citral against Candida albicans,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 378280, 9 pages, 2014. View at Publisher · View at Google Scholar
  22. A. Escalante, M. Gattuso, P. Pérez, and S. Zacchino, “Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman,” Journal of Natural Products, vol. 71, no. 10, pp. 1720–1725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. G. M. Eliopoulos and R. C. Moellering, “Antimicrobial combinations,” in Antibiotics in Laboratory Medicine, V. Lorian, Ed., pp. 434–441, Lippincott Williams & Wilkins, Baltimore, Md, USA, 1991. View at Google Scholar
  24. F. Q. S. Guerra, J. M. Mendes, J. P. D. Sousa et al., “Increasing antibiotic activity against a multidrug-resistant Acinetobacter spp by essential oils of Citrus limon and Cinnamomum zeylanicum,” Natural Product Research, vol. 26, no. 23, pp. 2235–2238, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. H. D. M. Coutinho, J. G. M. Costa, E. O. Lima, V. S. Falcão-Silva, and J. P. Siqueira Jr., “Enhancement of the antibiotic activity against a multiresistant Escherichia coli by Mentha arvensis L. and chlorpromazine,” Chemotherapy, vol. 54, no. 4, pp. 328–330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. H. Chotirmall, B. Mirkovic, G. M. Lavelle, and N. G. McElvaney, “Immunoevasive Aspergillus virulence factors,” Mycopathologia, vol. 178, no. 5-6, pp. 363–370, 2014. View at Publisher · View at Google Scholar
  27. R. L. Cihlar, C. Kellogg, and J. R. S. Broedel, “Antifungal drugs targets: discovery and selection,” in Fungal Phatogenesis: Prenciples and Clinical Applications, R. A. Alderone and R. L. Cihlar, Eds., Marcel Dekker, New York, NY, USA, 2002. View at Google Scholar
  28. N. M. Martinez-Rossi, N. T. A. Perez, and A. Rossi, “Antifungal resistance mechanisms in dermathophytes,” Mycopathology, vol. 166, pp. 369–383, 2008. View at Publisher · View at Google Scholar
  29. J. M. Valgus, “What's new in antifungals?” Current Infectious Disease Reports, vol. 5, no. 1, pp. 16–21, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. G. P. Widodo, E. Y. Sukandar, and I. K. Adynyana, “Mechanism of action of coumarin against C. albicans by SEM/TEM analysis,” ITB Journal Science, vol. 44A, pp. 145–151, 2012. View at Google Scholar
  31. S. M. Razavi, “Plant coumarins as allelopathic agents,” International Journal of Biological Chemistry, vol. 5, no. 1, pp. 86–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Kupidlowska, K. Dobrzynska, E. Parys, and A. M. Zobel, “Effect of coumarin and xanthotoxin on mitochondrial structure, oxygen uptake, and succinate dehydrogenase activity in onion root cells,” Journal of Chemical Ecology, vol. 20, no. 10, pp. 2471–2480, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. J. A. Vazquez, “Combination antifungal therapy for mold infections: much ado about nothing?” Clinical Infectious Diseases, vol. 46, no. 12, pp. 1889–1901, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. R. D. Castro, Atividade antifúngica do óleo essencial de Cinnamomum zeylanicum Blume (Canela) e de sua associação com antifúngicos sintéticos sobre espécies de Candida [M.S. thesis], Federal University of Paraíba, João Pessoa, Brazil, 2010.
  35. R. E. Lewis, R. A. Prince, J. Chi, and D. P. Kontoyiannis, “Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 10, pp. 3208–3214, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. L. K. Najvar, A. Cacciapuoti, S. Hernandez et al., “Activity of Posaconazole Combined with Amphotericin B against Aspergillus flavus infection in mice: comparative studies in two Laboratories,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 3, pp. 758–764, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Elefanti, J. W. Mouton, P. E. Verweij, A. Tsakris, L. Zerva, and J. Meletiadis, “Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: effect of serum on inhibitory and fungicidal interactions,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 10, pp. 4656–4663, 2013. View at Publisher · View at Google Scholar · View at Scopus